Rapamycin Enhanced the Antitumor Effects of Doxorubicin in Myelogenous Leukemia K562 Cells by Downregulating the mTOR/p70S6K Pathway

Oncology Letters - Greece
doi 10.3892/ol.2019.10589
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications


Related search